COPD patients with severe COVID-19 had elevated serum levels of various inflammatory cytokines including IL-2R, IL-6, IL-8, IL-10, and TNF-α suggesting there may be global alterations in the immune response27. The gene discussed is IL6; the disease is COVID-19.